Contact Us
Linkedin-in

Category: Blog

Your blog category

Stonegate Capital Partners Updates Coverage on Civeo Corporation (NYSE: CVEO) 3Q25

CVEO reported revenue and adj EBITDA of $170.5M and $28.8M, respectively. This compares to our/consensus estimates of $175.9M/$173.5M and $27.7M/$27.8M, respectively. The year-over-year EBITDA increase reflected continued strength in Australia and the benefit of cost-cutting initiatives in Canada. Operating cash flow totaled $13.8M, while capital expenditures were $5.6M, primarily related to maintenance of lodges and […]

Stonegate Capital Partners Updates Coverage on Materion Corp (NYSE: MTRN) 3Q25

Materion’s 3Q25 results reflected another quarter of disciplined execution and margin resilience despite temporary operational headwinds. The Company delivered year-over-year growth in revenue and value-added sales, underpinned by record profitability in Electronic Materials and continued transformation in Precision Optics. Strength in semiconductor demand—particularly outside China—along with improving defense and energy sales, offset softness in automotive […]

Stonegate Capital Partners Initiates Research Coverage on Cassiar Gold Corp. (TSXV: GLDC)

Cassiar’s technical foundation has advanced materially, culminating in a June 2025 NI 43-101 technical report and updated mineral resource estimate for the Cassiar Gold Property. The pit-constrained Taurus MRE outlines Indicated Mineral Resources of 8.8 Mt at 1.43 g/t Au (410 koz) plus Inferred Mineral Resources of 63.2 Mt at 0.95 g/t Au (1.93 Moz) […]

Stonegate Capital Partners Initiates Coverage on NeOnc Technologies Holdings Inc. (NASDAQ: NTHI)

NeOnc Technologies Holdings, Inc. is a clinical-stage life sciences company developing central nervous system therapeutics designed to overcome the blood–brain barrier. The Company has numerous assets in its pipeline, highlighted by NEO100 which is a patented, pure pharmaceutical compound produced via proprietary synthesis for pharmaceutical-grade purity and reproducibility. NeOnc’s intranasal administration strategy is designed to […]

Stonegate Capital Partners Updates Coverage On Franklin Covey Co (NYSE: FC) 1Q26

Franklin Covey delivered performance in-line with expectations with very strong underlying metrics during 1Q as the Company returns to growth for FY26. Ultimately, we view the current situation as the leading edge of an acceleration, noting that the new go-to market strategy is resulting in strong logo growth, diligent cost cutting is expected to compound, […]

Stonegate Capital Partners Mid-Quarter Update on Heliostar Metals Ltd (TSXV: HSTR) 4Q25

Heliostar continued to advance its flagship Ana Paula project in Guerrero as a high-grade underground development asset, now highlighted by a positive PEA released in early 4Q25. The study outlines total recovered production of ~875,000 ounces over a nine-year mine life, with mill feed averaging 5.37 g/t gold and a 1,800 tpd underground operation producing […]

Stonegate Capital Partners Updates Coverage Initiates Report on Viemed Healthcare Inc. (NASDAQ: VMD)

Viemed Healthcare is the leading U.S. provider of in-home post-acute respiratory care, specializing in non-invasive ventilation (“NIV”) for patients with COPD and chronic respiratory failure. The Company delivers care through a clinician-driven, high-touch model that integrates respiratory therapists, proprietary clinical workflows, and continuous patient monitoring to improve outcomes and reduce total cost of care. While […]

Stonegate Capital Partners Initiates Coverage on ARMOUR Residential REIT Inc. (NYSE: ARR)

The Company ended the quarter with revenues, net income to common, and diluted EPS of $210.2M, $156.3M, and $1.49. This was a year over year increase of 65.4%, 148.5% and 23.2% respectively. This was primarily driven by the strong growth in average interest income on interest earning assets while interest cost on average interest-bearing liabilities […]

Stonegate Capital Partners Updates Coverage on Hooker Furniture Corporation (NASDAQ: HOFT) 3Q26

HOFT reported revenue, operating income, and adj EPS of $70.7M, ($16.3)M, and ($1.99), respectively. This compares to our/consensus estimates of $85.2M/$85.5M, ($2.2)M/($2.2)M, and ($0.15)/($0.14). Revenues came in below expectations, declining 32.2% y/y, driven primarily by the Company selling the majority of it’s HMI business segment. In contrast, Hooker Branded net sales grew 4.4% y/y and […]

AN TRAN SHELMIRE

Research Analyst

SAVANNAH BEAVER

TOM BAKER

Senior Advisor, IR & Communications

Tom is the CEO and cofounder of Reportable, a corporate communications and competitive intelligence software and service. Reportable is helping companies across all industries ranging from top venture-backed startups to publicly traded Fortune 500 companies. Tom has more than 20 years of experience working in corporate communications and investor relations for biotech and medical device companies. Tom graduated UCSD with a B.S. in Pharmacological Chemistry. An avid surfer, Tom grew up in San Diego and currently lives in the Boston area with his wife Melissa and 3 young boys.

LOUISE SHELMIRE

Compliance Advisor

Louise has been employed at Stonegate Capital Markets since 2018 as an independent contractor for compliance functions. Louise was previously with Tradestar Investments and Stockcross Financial Services. She has served as a Sales manager and Compliance Principal. Louise graduated with a BA from Louisiana State University. She currently holds FINRA Series 7, 63, 24, 53, 4, 65 and 9/10 licenses and is currently on a roster available to serve as a FINRA arbitrator.

TABER WETZ

M&A Due Diligence

Taber is a seasoned finance executive with relevant experience in corporate finance, mergers and acquisitions (M&A), and system implementations. He specializes in helping small and midsize companies grow by developing actionable recommendations for operational improvement. Taber has held senior roles such as CFO and COO for public companies ranging from $1 million to $100 million, and President of a merchant bank that raised over $75 million for an alternative energy startup. He earned his BS in Finance/Accounting from Oklahoma State University. Additionally, Taber has led four reverse mergers into public markets, developed and raised over $75 million in seasoned offerings, and successfully implemented POS and accounting systems for multiple companies. His expertise includes financial planning, risk management, and business development, driving significant growth and operational efficiency.

CHRIS GAUVIN

M&A Due Diligence

Chris is a strategic finance executive with extensive experience in accounting, finance, information systems, and strategy. He specializes in helping small and medium-sized companies grow by clarifying strategic vision and creating scalable processes. Chris has held senior roles such as Divisional CFO for a $200 million P&L, VP of Finance at a healthcare startup, and Director of M&A for a $1.5 billion public entity. He earned his Master of Accounting from The University of Texas at Austin and a BBA from Carleton University in Ottawa, Canada. Chris has led financial planning models for companies scaling rapidly, managed over 250 business valuation and due diligence transactions, and spearheaded strategic planning processes for entities with revenues exceeding $1 billion.

PAUL WHITLEY

Strategic Advisor, Stonegate Inc.

Managing Member CFO / COO / CRO
C‐Suite Support Inc.

Paul is a strategic Fractional CFO and Transformational Technology Leader. He joined Stonegate Capital Partners in 2024. His primary responsibilities include driving business growth through financial, operational, and digital transformation initiatives, as well as implementing quality of earnings assessments, preparing Confidential Information Memorandums (CIM), and providing valuation methodologies. Paul previously held senior roles in various high-profile companies, including Senior VP at a $2 billion hedge fund and CFO/COO at a $180 million public company. He earned his MBA in Internet Technology and E-Commerce from the University of Dallas and a BBA in Finance/Accounting from the University of North Texas. Paul is also known for his extensive experience in growing and sustaining shareholder value, system implementations, and mergers and acquisitions.

BOLTON CORWIN

Analyst, M&A Group

Bolton joined Stonegate in 2024. He attended the University of Oklahoma and studied in the school of Business. Bolton works with the Stonegate’s M&A group, interacting with private equity firms and family offices on Stonegate’s buy-side and sell-side transactional business.

ROBIN AGIR

Associate, Institutional Sales

Robin is an institutional sales associate. He joined Stonegate in 2022. He was formerly with SRG Capital Partners. He graduated from The University of North Texas with a degree in marketing and communications.

Maximus Alexander-Nino

Analyst, Equity Research

Maximus joined our equity research group in 2026. He was formerly an analyst at Raymond James and also spent 6 years in the Florida Army National Guard. Maximus graduated from the University of South Florida with a BS in Finance. He currently holds an SIE and Series 99 and is a CFA Level 1 Candidate. 

William Stetson

Associate, Institutional Sales

Will is an associate on the institutional sales desk. He joined Stonegate in 2026. He graduated from Texas Tech University with a degree in finance. Before joining Stonegate, he interned at Compass Group USA and played College Football at Kenyon College.

LAURA ENGEL, CPA

Senior Advisor,
Research

Laura joined Stonegate in 2011. Her background spans over 20 years in financial services, having held diverse roles in public and private accounting, consulting, and executive leadership. She has broad industry experience within the healthcare, medical technology, and private equity sectors among others, partnering with high-growth organizations as a senior financial officer and consultant. She graduated from the University of Virginia and is a Certified Public Accountant (CPA).

QUENTIN HARRAH

VP, Institutional Sales

Quentin is a Vice President. He joined Stonegate in 2021. He graduated from Louisiana State University with degrees in marketing and professional sales.

JUSTIN MARTIN

Managing Director,
Institutional Sales & ESG Advisory

Justin is a managing director and helps lead the institutional sales effort. He also advises issuers on ESG rating policies and best practices. He joined Stonegate in 2012 and graduated from Auburn University with a Bachelor of Science in Finance. Justin is licensed with Stonegate Capital Markets, Inc. and currently holds FINRA Series 7, 63, and 79 licenses.

ZACH AMREIN

Head of
Business Development, CCO & CFO

Zach is the Head of business development, Chief Compliance Officer, and our CFO. He joined Stonegate in 2016. He formerly worked in Finance at Legacy Housing. He graduated from the University of Kansas with degrees in Finance and Accounting. Zach is licensed with Stonegate Capital Markets, Inc. and currently holds FINRA Series 7, 24, and 27 licenses. 

DAVE STORMS, CFA

Director of Research
Stonegate Capital Partners

Dave joined Stonegate in 2022. He was most recently an equity research analyst at Goldman Sachs. He was formerly a Senior investment analyst at Beneficial Financial Group, an analyst at Valuation Research Corporation, and an investment analyst with The Board of Pensions (PCUSA) focused on public equities. He started his career at Vanguard after receiving his undergraduate degree from Rowan University and a Masters in investment management from Temple University. David is licensed with Stonegate Capital Partners and currently holds FINRA Series SIE, 7, 87.

PRESTON GRAHAM

Partner
Stonegate Capital Partners

Preston joined Stonegate in 2010. His primary responsibilities include managing the sales desk, overseeing our institutional outreach effort, and advising clients on capital markets strategy. He graduated from Santa Clara University with a degree in finance. Preston is licensed with Stonegate Capital Markets, Inc. and currently holds FINRA Series 7, 63, 79, and 99 licenses.

JESSE SHELMIRE

Co-CEO, Partner
Stonegate Capital Partners

Jesse is Co-CEO/Partner of Stonegate Capital Partners/Stonegate Capital Markets(Member FINRA/SIPC), and a Co-Founder of Stonegate Healthcare Partners. Jesse spent the first decade of his investment career in 1981 at Smith Barney in retail sales and then later at Jefferies in institutional sales. In the mid-90’s, Jesse was the Managing Director of Investment Banking for First London Securities where he managed public and private transactions. In 1999, Jesse joined Stonegate where he’s managed ~100 transactions and currently provides advisory services for both public and private companies with a focus on healthcare. Jesse received his Bachelor of Science in Economics in 1979 from The Wharton School of Business at the University of Pennsylvania. Jesse is licensed with Stonegate Capital Markets and currently holds FINRA Series 7,24, 63, 79, 99 licenses.

SCOTT GRIFFITH

Co-CEO, Partner
Stonegate Capital Partners

Scott joined Stonegate in 1992 and is a co-owner of Stonegate. Prior to joining Stonegate, Scott was a Vice-President at Donaldson, Lufkin, & Jenrette from 1980 to 1988 and a Vice-President at Smith Barney from 1988 to 1992. He received his Bachelor of Science in Marketing from Florida State University in 1979. Scott is licensed with Stonegate Capital Markets and currently holds FINRA Series 7, 14, 24, 63, 79, 99 licenses.